echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > [Science] Heavy!

    [Science] Heavy!

    • Last Update: 2021-10-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    This article is original by Translational Medicine Network.
    Please indicate the source for reprinting.
    Author: Tiffany Guide: With the spread of the new crown virus worldwide, all walks of life have taken positive actions
    .

    It is not only the government, medical staff, but also the scientific community that have made tremendous efforts.
    These scientists are actively conducting experiments to study the characteristics of the new coronavirus, so as to develop more effective ways to resist and treat habits
    .

    In the course of these studies, scientists have continued to make surprising discoveries
    .

    Recently, scientists from Berlin made another horrifying discovery: People who have been infected with other coronaviruses before and have suffered from the common cold will have a certain degree of resistance to the new coronavirus
    .

    what the hell is it? In medicine, the reaction of antibodies or sensitized lymphocytes with different antigens with the same or similar epitopes is called cross-reaction
    .

    Because of the existence of the common antigen, the antibodies produced by the two kinds of cells stimulated by the body can not only bind to the corresponding epitopes on their own surface respectively, but the antibodies produced by the stimulated body by the A bacteria can also bind to the same epitopes on the surface of the B bacteria; Similarly, the antibodies produced by Bacteria stimulating the body can also bind to the same epitopes on the surface of Abacteria, but the degree of reaction is relatively weak.
    This kind of antigen and antibody reaction is called cross-reaction
    .

    The formation of cross-reaction phenomenon may be related to the following factors:-common antigen, some biological macromolecules of different organisms have the same antigen structure;-common epitope, some fragments (peptides) of different biological macromolecules have the same The epitope;-similar epitopes, different biological macromolecules, part of the spatial conformation of the epitopes is very similar, and can fit the complementarity determining region of the same antibody
    .

    The new discoveries of Berlin scientists to be described in this article are inseparable from the principle of cross-reaction.

    .

    The picture shows Charretti Berlin Medical University from Charretti Berlin Medical University [1], Berlin Institute of Health, and Max Planck Institute of Molecular Genetics researchers found through their latest study: For those who have been People who have been infected by a certain type of coronavirus and suffering from the common cold have certain immune cells in their bodies that can help them enhance their immune response to the new coronavirus, whether it is during natural infection or after vaccination , They are able to resist the new coronavirus better than others
    .

    They published the results of this research in an article titled "Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination" in "Science" magazine: In research and experiments, they also found that: This "immune cross-reaction ability" will slowly decline with age
    .

    This feature helps researchers explain why the elderly are more susceptible to serious diseases and why they are often weaker in immunity after being vaccinated than young people
    .

    Last year, researchers at Charretti Berlin Medical University and the Max Planck Institute for Molecular Genetics were shocked to discover that some people who have not been infected with the new coronavirus actually have immune memory cells that can help them recognize the new coronavirus, and These scientists reported this discovery for the first time
    .

    They then came to this conclusion: The reason why these T helper cells can be generated in these people who have not been infected with the new crown is because these people must have been infected with other coronaviruses before; however, those who have previously infected them.
    Most of the viruses are harmless, which means that they will not cause a big impact on life; because the structure of those coronaviruses is similar to the current new coronaviruses, (especially the characteristics of the spike protein located on the outer surface of the coronaviruses and the new coronaviruses The spike protein properties of T-helper cells are very similar), these T helper cells will also attack the new coronavirus like other coronaviruses
    .

    This "cross-reaction" hypothesis has been fully confirmed through a variety of experiments by scientists
    .

    However, whether these immune cells will affect the follow-up process of the new coronavirus infection is still unclear, and it is also one of the subjects of intense debate in the scientific community
    .

    Dr.
    Lucie Loyal is the first author of this paper and a researcher at Charretti Berlin Medical University and the Berlin Health Institute Regenerative Therapy Center.
    She explained: “Our assumption at the time was that people involved in this cross-reaction T helper cells have a certain protective effect on the human body and can play a role in resisting viral infections
    .

    Therefore, those who have previously been infected with the epidemic coronavirus (ie: the long-existing and widely spreading coronavirus) will have symptoms when they are infected with the new coronavirus.
    It will be weakened
    .

    However, in some cases, the facts may be just the opposite
    .

    If people are infected with certain viruses (involving similar strains) a second time, it will easily lead to a false immune response and negatively affect the clinical medical process.
    Influence, bring about negative effects
    .

    " In the current study, the Berlin research team provided evidence to support their previous assumptions about the existence of protection
    .

    According to their data, immune cross-reaction may not only be one of several potential reasons for changes in the severity of the new coronary disease, but also help explain why the efficacy of the vaccine varies among different age groups
    .

    The quality of the immune response to the new coronavirus, that is, the strength of the immune response, is related to the number of cross-reactive cells that existed in the body before the new coronavirus was infected
    .

    These T helper cells are particularly effective in recognizing specific regions of the spike protein
    .

    Because the genetic sequences of the epidemic coronavirus and the new coronavirus are very similar and have been well preserved, the specific region of this spike protein can be easily identified
    .

    In the current study, the researchers recruited some people who had not been infected with the new crown virus before, and regularly performed nucleic acid tests on them to check whether they were infected with the new crown
    .

    Starting in mid-2020, 17 of the nearly 800 participants they recruited have tested positive
    .

    Researchers immediately conducted detailed observations and analyses of the immune systems of these new crown patients
    .

    Through analysis, they found that one of the factors that determine whether an individual has a certain immune response to the new coronavirus is: the role of T helper cells-if the new coronavirus patient has been infected by other common cold viruses before, then T Helper cells have already been generated, and these cells can now play a major immune role in fighting the new coronavirus
    .

    The quality of the immune response to the new coronavirus, that is, the strength of the immune response, is related to the number of cross-reactive cells that existed in the body before the new coronavirus was infected
    .

    These T helper cells are particularly effective in recognizing specific regions of the spike protein
    .

    Because the genetic sequences of the epidemic coronavirus and the new coronavirus are very similar and have been well preserved, the specific region of this spike protein can be easily identified
    .

    Dr.
    Claudia Giesecke-Thiel, the corresponding author of this paper and the head of the flow cytometry service team of the Max Planck Institute of Molecular Genetics, explained: “During infection with other harmless coronaviruses, the immune system will establish a A protective universal memory of the'coronavirus'.
    Once infected with the new coronavirus, these memory cells will be reactivated and initiate a response to newly invading pathogens
    .

    This will help to accelerate the initial immune response to the new coronavirus , and In the early stage of infection, the spread of the virus can be suppressed, which plays an important and positive role in the treatment of the disease
    .

    This does not mean that people who have been infected with the common cold virus will definitely be protected from the new crown virus, nor will it change the current situation of the new crown pandemic
    .

    There is no doubt that there are not a few people who have been infected with other coronaviruses before, but they are also infected with the new crown.
    From this point of view, this does not reduce the importance of vaccination
    .

    Our research results provide an explanation for our observations of patients since the outbreak, and explain to a certain extent why patients with new crowns are also patients with new crowns, but the symptoms of infection are very different between individuals
    .

    This further confirms that the resistance and immunity of T cells generated by the cross-reaction to the virus will also be enhanced after vaccination with the new crown vaccine
    .

    Just like a natural infection, the vaccine promotes the production of the spike protein of the new coronavirus in the body (including its well-preserved parts) and provides these spike proteins for the immune system
    .

    We analyzed the immune response of the 31 healthy people.
    After vaccinating them, their immune system reacted differently from before the vaccination.
    The difference between before and after shows that normal T helper cells need to be vaccinated after vaccination.
    It is gradually activated within two weeks; however, the activation of cross-reactive T helper cells is very rapid and can be activated within a week
    .

    Of course, this also has a particularly positive effect on the production of antibodies
    .

    This speeds up the production of antibodies, so that after the first dose of vaccine, people can produce antibodies against the remaining part of the spike.
    This antibody is usually produced after vaccination booster shots
    .

    "Even after vaccination, this person can use at least part of the immune memory if he has been infected with other influenza coronaviruses before
    .

    This explains well why after people were vaccinated with the new crown vaccine for the first time, among young people, the immunity and protection brought by the vaccine were produced so quickly.
    Not only that, but the protection is also very strong.

    .

    In the second part of the scientists' study, the researchers analyzed the T helper cells of about 570 healthy individuals, and they observed that the immune cross-reactivity of the elderly is gradually decreasing
    .

    In fact, in these elderly people, the number of cross-reactive T cells and their ability to bind pathogens are much weaker than those in young people
    .

    This decline in immune cross-reactivity is normal, which is caused by age-related changes
    .

    Professor Thiel said: “Infection with influenza coronavirus is good for young people because it will help them weaken the damage caused by the new coronavirus
    .

    Unfortunately, this benefit does not play a big role in the elderly
    .

    The third dose (booster) will be able to compensate for this weak immune response and ensure that this high-risk group has sufficient immunity to the new coronavirus
    .

    " [1] The Charity Medical University Berlin has a strong tradition and is also the largest in Europe.
    The teaching hospital affiliated to the university
    .

    It was established as a quarantine hospital outside Berlin in 1710
    .

    After a century, the clinic was completely rebuilt and became the medical department of the newly established University of Berlin
    .

    It has four campuses
    .

    Adhering to the motto of "research, teaching, treatment, and help", academic teaching, research and patient care have become an inseparable whole
    .

    In Germany, it is a medical school on par with Heidelberg University
    .

    Reference materials: https://medicalxpress.
    com/news/2021-09-prior-exposure-common-cold-coronaviruses.
    html Note: This article aims to introduce medical research progress and cannot be used as a reference for treatment options
    .

    If you need health guidance, please go to a regular hospital
    .

    Popular·Article Scientific Research [NEJM] It's time for us to change the salt! A landmark study proved that simply changing the salt can prevent millions of deaths every year.
    Scientific research [Nature Sub-Journal] Unprecedented clarity and speed: For the first time, the new microscope technology recorded more than 1 million neurons in the entire mouse brain Cortical activity gene detection [Nature sub-Journal] The 1.
    5 million largest genome-wide association study has identified nearly 600 gene loci related to antisocial behavior, alcoholism, and opioid addiction.
    New coronavirus [NEJM New Crown] in the world The largest new coronavirus vaccine safety research results released liquid biopsy [Science Sub-Journal] Biomarkers that can be determined based on blood samples-predict patient response to immunotherapy The safest medicine for the treatment of new crown infections!" The clinical trial results are out! Organoids [Nature Sub-Journal] The use of 3D brain organoids induced by stem cells can accurately replicate human brain cancer early screening [Nature Sub-Journal] A new non-invasive early screening method for lung cancer based on blood cfDNA, with ultra-high detection rate! Organoids [Science Sub-Journal] Subversion! It is the first time that a complete living tumor is 3D printed, and cancer exploration has entered the "real" 3D era.
    Gene editing [Nature Sub-Journal] is a heavyweight! Academician Ye Yuru’s team used genome editing technology to treat Alzheimer’s disease and achieved a major breakthrough in early cancer screening [The Lancet] Subverting traditional detection methods and achieving a new breakthrough in early prostate cancer screening.
    Scientific research [Discovery] Recounting Nobel Prize winners 1944 According to the experimental data of Vitamin C, it was found that the 2 times the recommended dose recommended by the WHO should be used.
    Activities The 3rd Shanghai International Cancer Conference The 5th Modern Clinical Molecular Diagnosis Symposium
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.